0001225208-16-026014.txt : 20160210
0001225208-16-026014.hdr.sgml : 20160210
20160210174515
ACCESSION NUMBER: 0001225208-16-026014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160208
FILED AS OF DATE: 20160210
DATE AS OF CHANGE: 20160210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEILAND JOHN H
CENTRAL INDEX KEY: 0001204663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 161406933
MAIL ADDRESS:
STREET 1: C/O C.R BARD INC
STREET 2: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2016-02-08
0000009892
BARD C R INC /NJ/
BCR
0001204663
WEILAND JOHN H
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
1
President and COO
Common Stock
2016-02-08
4
F
0
5433.0000
179.8050
D
61976.2900
D
Common Stock
2016-02-09
4
S
0
699.0000
182.4768
D
61277.2900
D
Common Stock
2016-02-09
4
S
0
2208.0000
181.7767
D
59069.2900
D
Common Stock
2016-02-09
4
S
0
5991.0000
180.6930
D
53078.2900
D
Common Stock
5864.1660
I
401(k) Plan
Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
Sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $182.35 to $182.69. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $181.29 to $182.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $180.26 to $181.14. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 32.702 shares acquired under the Company's 401(k) Plan from November 7, 2015 to February 5, 2016.
Myra McGinley, Attorney-in-Fact
2016-02-10